Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing

Background and Objectives Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lasers in surgery and medicine 2005-01, Vol.36 (1), p.47-51
Hauptverfasser: Kim, Yong Ju, Lee, Ho-Sup, Son, Sang-Wook, Kim, Soo-Nam, Kye, Young-Chul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 51
container_issue 1
container_start_page 47
container_title Lasers in surgery and medicine
container_volume 36
creator Kim, Yong Ju
Lee, Ho-Sup
Son, Sang-Wook
Kim, Soo-Nam
Kye, Young-Chul
description Background and Objectives Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmentation following Er:YAG laser resurfacing, especially in darker skin. Study Design/Materials and Methods One hundred and ninety patients (skin phototypes III and above), treated with Er:YAG lasers—short‐pulsed and modulated (variable‐pulsed and dual‐mode) Er:YAG lasers—for skin resurfacing were recruited. The clinical features of hyperpigmentation and hypopigmentation were evaluated retrospectively using medical charts and serial photographs. For histopathologic examinations, skin biopsies were performed in three patients at hyperpigmentation sites and in four patients at hypopigmentation sites. Results Hyperpigmentation was observed in 38.4% of the patients. Mean onset and duration were 3.5 and 7.2 weeks, and then it has faded away within 16 weeks in 93.2% of cases. Hypopigmentation was observed in 13.7% of the patients; its mean onset was 2 months after treatment, and it faded within 1 year in 85% of cases. The incidences and mean durations of these side effects were more intense and longer in patients treated with short‐pulsed, variable‐pulsed, and dual‐mode Er:YAG lasers, in increasing order. In terms of histopathologic examinations, melanin amounts in the epidermal basal layer were observed to vary. Conclusions Hyperpigmentation and hypopigmentation are frequent complications of Er:YAG laser resurfacing. Long pulse duration‐induced thermal damage seems to be the most important factor in terms of the induction of pigmentary disorders. Lasers Surg. Med. 36:47–51, 2005. © 2005 Wiley‐Liss, Inc.
doi_str_mv 10.1002/lsm.20120
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19429209</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19429209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3920-e72b70ba02b1813e18e1580e528f7e2759438c3b883d43f38a2e0fec923820e73</originalsourceid><addsrcrecordid>eNp1kE1PAjEQhhujEUQP_gGzJxMPC9N2l3a9EcKHCeoB1HhqusssVvYD2yXKv3cR1Hgwc5iZN8-8k7yEnFNoUwDWyVzeZkAZHJAmhajrRxToIWkCrWcJEWuQE-deAYAzEMekQcNul9XVJI-9QmcbZ5xXpt7LZoV2ZRY5FpWuTFl4uphv1fKvmFZovYG9fu6NvEy7enFLU3gW3dqmOjHF4pQcpTpzeLbvLfIwHMz6Y39yP7rp9yZ-wiMGPgoWC4g1sJhKypFKpKEEDJlMBTIRRgGXCY-l5POAp1xqhpBiEjEuGaDgLXK5813Z8m2NrlK5cQlmmS6wXDtFo4DVj6IavNqBiS2ds5iqlTW5thtFQW1DVHWI6ivEmr3Ym67jHOe_5D61GujsgHeT4eZ_JzWZ3n5b-rsL4yr8-LnQdqm6gotQPd2N1EyMh9MgGCrJPwGVIIpl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19429209</pqid></control><display><type>article</type><title>Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Kim, Yong Ju ; Lee, Ho-Sup ; Son, Sang-Wook ; Kim, Soo-Nam ; Kye, Young-Chul</creator><creatorcontrib>Kim, Yong Ju ; Lee, Ho-Sup ; Son, Sang-Wook ; Kim, Soo-Nam ; Kye, Young-Chul</creatorcontrib><description>Background and Objectives Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmentation following Er:YAG laser resurfacing, especially in darker skin. Study Design/Materials and Methods One hundred and ninety patients (skin phototypes III and above), treated with Er:YAG lasers—short‐pulsed and modulated (variable‐pulsed and dual‐mode) Er:YAG lasers—for skin resurfacing were recruited. The clinical features of hyperpigmentation and hypopigmentation were evaluated retrospectively using medical charts and serial photographs. For histopathologic examinations, skin biopsies were performed in three patients at hyperpigmentation sites and in four patients at hypopigmentation sites. Results Hyperpigmentation was observed in 38.4% of the patients. Mean onset and duration were 3.5 and 7.2 weeks, and then it has faded away within 16 weeks in 93.2% of cases. Hypopigmentation was observed in 13.7% of the patients; its mean onset was 2 months after treatment, and it faded within 1 year in 85% of cases. The incidences and mean durations of these side effects were more intense and longer in patients treated with short‐pulsed, variable‐pulsed, and dual‐mode Er:YAG lasers, in increasing order. In terms of histopathologic examinations, melanin amounts in the epidermal basal layer were observed to vary. Conclusions Hyperpigmentation and hypopigmentation are frequent complications of Er:YAG laser resurfacing. Long pulse duration‐induced thermal damage seems to be the most important factor in terms of the induction of pigmentary disorders. Lasers Surg. Med. 36:47–51, 2005. © 2005 Wiley‐Liss, Inc.</description><identifier>ISSN: 0196-8092</identifier><identifier>EISSN: 1096-9101</identifier><identifier>DOI: 10.1002/lsm.20120</identifier><identifier>PMID: 15662626</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Cicatrix - radiotherapy ; Er:YAG laser resurfacing ; Female ; Follow-Up Studies ; Humans ; Hydroquinones - therapeutic use ; hyperpigmentation ; Hyperpigmentation - drug therapy ; Hyperpigmentation - etiology ; Hyperpigmentation - pathology ; hypopigmentation ; Hypopigmentation - etiology ; Hypopigmentation - pathology ; Lasers - adverse effects ; Male ; Middle Aged ; Radiation-Protective Agents - therapeutic use ; Remission, Spontaneous ; Retrospective Studies ; Time Factors</subject><ispartof>Lasers in surgery and medicine, 2005-01, Vol.36 (1), p.47-51</ispartof><rights>Copyright © 2005 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3920-e72b70ba02b1813e18e1580e528f7e2759438c3b883d43f38a2e0fec923820e73</citedby><cites>FETCH-LOGICAL-c3920-e72b70ba02b1813e18e1580e528f7e2759438c3b883d43f38a2e0fec923820e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Flsm.20120$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Flsm.20120$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15662626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Yong Ju</creatorcontrib><creatorcontrib>Lee, Ho-Sup</creatorcontrib><creatorcontrib>Son, Sang-Wook</creatorcontrib><creatorcontrib>Kim, Soo-Nam</creatorcontrib><creatorcontrib>Kye, Young-Chul</creatorcontrib><title>Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing</title><title>Lasers in surgery and medicine</title><addtitle>Lasers Surg. Med</addtitle><description>Background and Objectives Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmentation following Er:YAG laser resurfacing, especially in darker skin. Study Design/Materials and Methods One hundred and ninety patients (skin phototypes III and above), treated with Er:YAG lasers—short‐pulsed and modulated (variable‐pulsed and dual‐mode) Er:YAG lasers—for skin resurfacing were recruited. The clinical features of hyperpigmentation and hypopigmentation were evaluated retrospectively using medical charts and serial photographs. For histopathologic examinations, skin biopsies were performed in three patients at hyperpigmentation sites and in four patients at hypopigmentation sites. Results Hyperpigmentation was observed in 38.4% of the patients. Mean onset and duration were 3.5 and 7.2 weeks, and then it has faded away within 16 weeks in 93.2% of cases. Hypopigmentation was observed in 13.7% of the patients; its mean onset was 2 months after treatment, and it faded within 1 year in 85% of cases. The incidences and mean durations of these side effects were more intense and longer in patients treated with short‐pulsed, variable‐pulsed, and dual‐mode Er:YAG lasers, in increasing order. In terms of histopathologic examinations, melanin amounts in the epidermal basal layer were observed to vary. Conclusions Hyperpigmentation and hypopigmentation are frequent complications of Er:YAG laser resurfacing. Long pulse duration‐induced thermal damage seems to be the most important factor in terms of the induction of pigmentary disorders. Lasers Surg. Med. 36:47–51, 2005. © 2005 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>Cicatrix - radiotherapy</subject><subject>Er:YAG laser resurfacing</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hydroquinones - therapeutic use</subject><subject>hyperpigmentation</subject><subject>Hyperpigmentation - drug therapy</subject><subject>Hyperpigmentation - etiology</subject><subject>Hyperpigmentation - pathology</subject><subject>hypopigmentation</subject><subject>Hypopigmentation - etiology</subject><subject>Hypopigmentation - pathology</subject><subject>Lasers - adverse effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Radiation-Protective Agents - therapeutic use</subject><subject>Remission, Spontaneous</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><issn>0196-8092</issn><issn>1096-9101</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1PAjEQhhujEUQP_gGzJxMPC9N2l3a9EcKHCeoB1HhqusssVvYD2yXKv3cR1Hgwc5iZN8-8k7yEnFNoUwDWyVzeZkAZHJAmhajrRxToIWkCrWcJEWuQE-deAYAzEMekQcNul9XVJI-9QmcbZ5xXpt7LZoV2ZRY5FpWuTFl4uphv1fKvmFZovYG9fu6NvEy7enFLU3gW3dqmOjHF4pQcpTpzeLbvLfIwHMz6Y39yP7rp9yZ-wiMGPgoWC4g1sJhKypFKpKEEDJlMBTIRRgGXCY-l5POAp1xqhpBiEjEuGaDgLXK5813Z8m2NrlK5cQlmmS6wXDtFo4DVj6IavNqBiS2ds5iqlTW5thtFQW1DVHWI6ivEmr3Ym67jHOe_5D61GujsgHeT4eZ_JzWZ3n5b-rsL4yr8-LnQdqm6gotQPd2N1EyMh9MgGCrJPwGVIIpl</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Kim, Yong Ju</creator><creator>Lee, Ho-Sup</creator><creator>Son, Sang-Wook</creator><creator>Kim, Soo-Nam</creator><creator>Kye, Young-Chul</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>200501</creationdate><title>Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing</title><author>Kim, Yong Ju ; Lee, Ho-Sup ; Son, Sang-Wook ; Kim, Soo-Nam ; Kye, Young-Chul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3920-e72b70ba02b1813e18e1580e528f7e2759438c3b883d43f38a2e0fec923820e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Cicatrix - radiotherapy</topic><topic>Er:YAG laser resurfacing</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hydroquinones - therapeutic use</topic><topic>hyperpigmentation</topic><topic>Hyperpigmentation - drug therapy</topic><topic>Hyperpigmentation - etiology</topic><topic>Hyperpigmentation - pathology</topic><topic>hypopigmentation</topic><topic>Hypopigmentation - etiology</topic><topic>Hypopigmentation - pathology</topic><topic>Lasers - adverse effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Radiation-Protective Agents - therapeutic use</topic><topic>Remission, Spontaneous</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Yong Ju</creatorcontrib><creatorcontrib>Lee, Ho-Sup</creatorcontrib><creatorcontrib>Son, Sang-Wook</creatorcontrib><creatorcontrib>Kim, Soo-Nam</creatorcontrib><creatorcontrib>Kye, Young-Chul</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Lasers in surgery and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Yong Ju</au><au>Lee, Ho-Sup</au><au>Son, Sang-Wook</au><au>Kim, Soo-Nam</au><au>Kye, Young-Chul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing</atitle><jtitle>Lasers in surgery and medicine</jtitle><addtitle>Lasers Surg. Med</addtitle><date>2005-01</date><risdate>2005</risdate><volume>36</volume><issue>1</issue><spage>47</spage><epage>51</epage><pages>47-51</pages><issn>0196-8092</issn><eissn>1096-9101</eissn><abstract>Background and Objectives Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmentation following Er:YAG laser resurfacing, especially in darker skin. Study Design/Materials and Methods One hundred and ninety patients (skin phototypes III and above), treated with Er:YAG lasers—short‐pulsed and modulated (variable‐pulsed and dual‐mode) Er:YAG lasers—for skin resurfacing were recruited. The clinical features of hyperpigmentation and hypopigmentation were evaluated retrospectively using medical charts and serial photographs. For histopathologic examinations, skin biopsies were performed in three patients at hyperpigmentation sites and in four patients at hypopigmentation sites. Results Hyperpigmentation was observed in 38.4% of the patients. Mean onset and duration were 3.5 and 7.2 weeks, and then it has faded away within 16 weeks in 93.2% of cases. Hypopigmentation was observed in 13.7% of the patients; its mean onset was 2 months after treatment, and it faded within 1 year in 85% of cases. The incidences and mean durations of these side effects were more intense and longer in patients treated with short‐pulsed, variable‐pulsed, and dual‐mode Er:YAG lasers, in increasing order. In terms of histopathologic examinations, melanin amounts in the epidermal basal layer were observed to vary. Conclusions Hyperpigmentation and hypopigmentation are frequent complications of Er:YAG laser resurfacing. Long pulse duration‐induced thermal damage seems to be the most important factor in terms of the induction of pigmentary disorders. Lasers Surg. Med. 36:47–51, 2005. © 2005 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15662626</pmid><doi>10.1002/lsm.20120</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0196-8092
ispartof Lasers in surgery and medicine, 2005-01, Vol.36 (1), p.47-51
issn 0196-8092
1096-9101
language eng
recordid cdi_proquest_miscellaneous_19429209
source MEDLINE; Wiley Online Library All Journals
subjects Adult
Cicatrix - radiotherapy
Er:YAG laser resurfacing
Female
Follow-Up Studies
Humans
Hydroquinones - therapeutic use
hyperpigmentation
Hyperpigmentation - drug therapy
Hyperpigmentation - etiology
Hyperpigmentation - pathology
hypopigmentation
Hypopigmentation - etiology
Hypopigmentation - pathology
Lasers - adverse effects
Male
Middle Aged
Radiation-Protective Agents - therapeutic use
Remission, Spontaneous
Retrospective Studies
Time Factors
title Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A01%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20hyperpigmentation%20and%20hypopigmentation%20after%20Er:YAG%20laser%20skin%20resurfacing&rft.jtitle=Lasers%20in%20surgery%20and%20medicine&rft.au=Kim,%20Yong%20Ju&rft.date=2005-01&rft.volume=36&rft.issue=1&rft.spage=47&rft.epage=51&rft.pages=47-51&rft.issn=0196-8092&rft.eissn=1096-9101&rft_id=info:doi/10.1002/lsm.20120&rft_dat=%3Cproquest_cross%3E19429209%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19429209&rft_id=info:pmid/15662626&rfr_iscdi=true